These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28385249)

  • 1. Enhanced immune response to inactivated porcine circovirus type 2 (PCV2) vaccine by conjugation of chitosan oligosaccharides.
    Zhang G; Jia P; Cheng G; Jiao S; Ren L; Ji S; Hu T; Liu H; Du Y
    Carbohydr Polym; 2017 Jun; 166():64-72. PubMed ID: 28385249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Positive Correlation of the Enhanced Immune Response to PCV2 Subunit Vaccine by Conjugation of Chitosan Oligosaccharide with the Deacetylation Degree.
    Zhang G; Cheng G; Jia P; Jiao S; Feng C; Hu T; Liu H; Du Y
    Mar Drugs; 2017 Jul; 15(8):. PubMed ID: 28933754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of chitosan oligosaccharides via a carrier protein markedly improves immunogenicity of porcine circovirus vaccine.
    Zhang G; Jia P; Liu H; Hu T; Du Y
    Glycoconj J; 2018 Oct; 35(5):451-459. PubMed ID: 30051156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conjugation of chitosan oligosaccharides enhances immune response to porcine circovirus vaccine by activating macrophages.
    Zhang G; Jia P; Liu H; Hu T; Du Y
    Immunobiology; 2018 Nov; 223(11):663-670. PubMed ID: 30005969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One dose of a porcine circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions.
    Martelli P; Ferrari L; Morganti M; De Angelis E; Bonilauri P; Guazzetti S; Caleffi A; Borghetti P
    Vet Microbiol; 2011 May; 149(3-4):339-51. PubMed ID: 21216540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of the Immunogenicity of Porcine Circovirus Type 2 DNA Vaccine by Recombinant ORF2 Gene and CpG Motifs.
    Li J; Shi JL; Wu XY; Fu F; Yu J; Yuan XY; Peng Z; Cong XY; Xu SJ; Sun WB; Cheng KH; Du YJ; Wu JQ; Wang JB; Huang BH
    Viral Immunol; 2015 Jun; 28(5):290-6. PubMed ID: 26046831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orf virus as an adjuvant enhances the immune response to a PCV2 subunit vaccine.
    Sun J; Ma J; Chen L; Xiao S; Xiao X; Fang L
    Vet Microbiol; 2024 Jun; 293():110088. PubMed ID: 38640639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions.
    Seo HW; Han K; Oh Y; Park C; Chae C
    Vaccine; 2012 Oct; 30(47):6671-7. PubMed ID: 22963801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, virological, immunological and pathological evaluation of four porcine circovirus type 2 vaccines.
    Seo HW; Han K; Park C; Chae C
    Vet J; 2014 Apr; 200(1):65-70. PubMed ID: 24618398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice.
    Liu X; Ouyang T; Ma T; Ouyang H; Pang D; Ren L
    BMC Vet Res; 2018 Apr; 14(1):137. PubMed ID: 29685143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD40 Ligand and GMCSF Coexpression Enhance the Immune Responses and Protective Efficacy of PCV2 Adenovirus Vaccine.
    Li D; Huang Y; Du Q; Wang Z; Chang L; Zhao X; Tong D
    Viral Immunol; 2016 Apr; 29(3):148-58. PubMed ID: 26982652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration.
    Bucarey SA; Pujol M; Poblete J; Nuñez I; Tapia CV; Neira-Carrillo A; Martinez J; Bassa O
    Virol J; 2014 Aug; 11():149. PubMed ID: 25141864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
    Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
    Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and immunogenicity of porcine circovirus type 2 chimeric virus-like particles displaying porcine reproductive and respiratory syndrome virus GP5 epitope B.
    Hu G; Wang N; Yu W; Wang Z; Zou Y; Zhang Y; Wang A; Deng Z; Yang Y
    Vaccine; 2016 Apr; 34(16):1896-903. PubMed ID: 26930366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
    Li PC; Qiao XW; Zheng QS; Hou JB
    Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective efficacy of a DNA vaccine encoding capsid protein of porcine circovirus-like virus P1 against porcine circovirus 2 in mice.
    Zhang D; He K; Wen L; Fan H
    Microbiol Immunol; 2018 Mar; 62(3):195-199. PubMed ID: 29315776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.